The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE tracks Europe higher on trade hopes; Shire shines

Fri, 14th Sep 2018 10:16

(For a live blog on European stocks, type LIVE/ in an Eikonnews window)

* FTSE 100 up 0.1 pct

* Shire gains after China nod to Takeda deal

* Housebuilders under pressure

* Investec rallies on spin-off plans

By Danilo Masoni

MILAN, Sept 14 (Reuters) - Britain's top share index trackedhigher European markets on Friday with the mood buoyed by easingtrade worries, while Shire rose after China cleared Takeda'splans to buy the drugmaker.

The FTSE 100 was up 0.1 percent by 0857 GMT,underpinned by gains among the energy and healthcare sectors,which more than offset weakness among utilities, hit earlierthis week by a profit warning from SSE.

"Traders (are) hopeful about U.S.-China trade talks despitePresident Trump being the fly in the ointment, downplayingprospects for quick negotiations," Accendo Markets analayst Mikevan Dulken said.

Trump said on Thursday that the United States was under nopressure to make a trade deal with China, even as Chineseofficials welcomed an invitation from Washington for a new roundof talks with more U.S. tariffs looming.

The FTSE was set for a small weekly gain following twoconsecutive weeks of losses partly due to a rally in the poundon prospects of a Brexit deal with the European Union.

On Friday the pound rose further, touching its highest levelsince early August. The index, whose constituents make more thantwo-thirds of their sales abroad, shrugged off the latest movein the pound but it remains down 5.3 percent so far in 2018.

Shire rose 1.5 percent.

Takeda Pharmaceutical said China approved itspurchase of Shire, the latest regulator to clear the $62 billiondeal and bring the Japanese group closer to becoming a globaltop 10 drugmaker.

Taked expects the deal to close in the first half of 2019although it needs shareholder approval to raise the funds to payfor the $62 billion deal.

British housebuilders were under pressure after Bank ofEngland governor Mark Carney was reported in The Times as havingtold ministers that a no-deal Brexit could cause house prices tofall by 35 percent over three years.

Barrat Developments and Taylor Wimpey wereboth down around 1 percent, among the top fallers on the FTSE.

Mid-cap Investec rose 8 percent on news it plans tohive off and separately list its asset management unit in arestructuring that comes as the long-serving company founderleaves the financial services group.

"Investec's plan to spin off its asset management arm lookslike a sensible decision as it should allow management morefreedom to drive that business forward and not be constrained byhaving to follow the strategy of the current parent which ispredominantly a specialist banking business," said Russ Mould,investment director at AJ Bell.

JD Wetherspoon declined 0.7 percent after the pubchain said it expected higher costs this year even though arecord heatwave that brought in more customers lifted itsfull-year profit.(Reporting by Danilo MasoniEditing by Mark Heinrich)

More News
6 Sep 2019 07:54

UPDATE 1-Sumitomo Dainippon Pharma investing $3 bln in Swiss Roivant in overseas push

* Dainippon to buy 10% stake in Roivant and interests in 5 units * Schizophrenia treatment Latuda to lose US exclusivity in 2023 * Japan pharma firms grapple with declining Dainippon

Read more
14 Aug 2019 06:45

UPDATE 1-Germany's Stada 'very selective' on acquisitions - CEO Goldschmidt

FRANKFURT, Aug 14 (Reuters) - German generic drugmaker Stada will be careful about buying businesses and companies outright, and for now will focus mainly on striking production and development we

Read more
17 Jul 2019 17:55

Takeda kicks off sale of Western European drugs - sources

By Arno Schuetze and Pamela Barbaglia FRANKFURT/LONDON, July 17 (Reuters) - Japan's Takeda Pharmaceutical Co has reached out to prospective bidders for a portfolio of drugs for sale in

Read more
16 May 2019 18:35

Japan's Takeda expects binding offers for Latam business by end of May -sources

By Tatiana Bautzer SAO PAULO, May 16 (Reuters) - Japan's Takeda Pharmaceutical Co expects to receive binding offers for its Latin American business by the end of May, three sources of a

Read more
15 May 2019 08:05

Nikkei snaps 7-day losing streak helped by China's stimulus hopes

* Gains may be short-lived - analyst * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi Estate jumps on share buyback, governance reform By Hideyuki Sano and Ayai

Read more
15 May 2019 04:04

Nikkei hobbled by trade worries, disappointing earnings

* Nikkei down slightly after 7 losing sessions * Uncertainties over U.S.-China standoff keep investors on edge * Takeda Pharma, Nissan sink after earnings shock * Mitsubishi -

Read more
14 May 2019 07:56

UPDATE 1-Japan's Takeda forecasts 193 bln yen annual operating loss on Shire deal

* 193 bln Y op loss forecast this yr vs 227.5 bln profit view of analysts * Shire acquisition made Takeda one of the world's most indebted drugmakers (Adds details of results, May 14 -

Read more
14 May 2019 07:39

Japan's Takeda expects annual loss on Shire deal

TOKYO, May 14 (Reuters) - Takeda Pharmaceutical Co forecast on Tuesday it would have an operating loss in the current financial year, as it books costs associated with the multibillion-dollar an a

Read more
9 May 2019 00:38

UPDATE 1-Novartis buys Takeda's dry eye drug for $3.4 bln

May 8 (Reuters) - Swiss drugmaker Novartis AG said on Wednesday it agreed to acquire Takeda Pharmaceutical Company Ltd's dry eye drug Xiidra for $3.4 billion, as well as potential milestone of

Read more
1 Feb 2019 06:07

Japan's Takeda posts 28 pct rise in Q3 operating profit

TOKYO, Feb 1 (Reuters) - Takeda Pharmaceutical Co Ltd on Friday posted a 27.9 percent rise in third-quarter operating profit, supported by strong sales of its drugs for bowel disease and multiple

Read more
22 Jan 2019 02:46

Nikkei dips as global growth concerns sap risk appetite

* IMF cuts global growth forecasts * Companies with big China exposure fall * Totech soars after raising earnings forecast By Ayai Tomisawa TOKYO, Jan 22 (Reuters) - in

Read more
8 Jan 2019 13:54

MARKET ANALYSIS: Optimism About Trade Talks May Generate Continued Buying Interest

WASHINGTON (Alliance News) - The major US index futures are pointing to a higher opening on Tuesday, with stocks likely to extend the strong upward move seen over the two previous about trade the

Read more
8 Jan 2019 08:58

Asian Shares Mixed Despite US-China Trade Deal Optimism

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in second day of

Read more
8 Jan 2019 07:39

Takeda takes control of Shire

(Sharecast News) - Takeda Pharmaceutical has taken full control of Shire after the legal particulars of its cash and share offer were completed.

Read more
7 Jan 2019 04:29

Takeda unlikely to sell OTC drug business -CEO

(Adds quote, other details) TOKYO, Jan 7 (Reuters) - Takeda Pharmaceutical is unlikely to sell its over-the-counter (OTC) drug business even amid pressure to improve its finances as it a a

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.